Palatal Expansion: Rapid vs Slow, Devices and Effects on the Midpalatal Suture

Palatal expansion is one of the most common procedures in pediatric and interceptive orthodontics, yet correct understanding of the biological mechanisms and the factors determining the extent of skeletal vs. dentoalveolar effect remains one of the areas of greatest heterogeneity in the literature and clinical practice. The fundamental distinction is between rapid palatal expansion (RPE) — aiming for mechanical opening of the midpalatal suture (MPS) before it obliterates — and slow palatal expansion (SPE) — mainly producing dentoalveolar tipping of the posterior segments, with a more modest secondary skeletal effect. Choosing between the two approaches can't be empirical but must be guided by analysis of the patient's biological age (MPS ossification), the extent of the transverse deficiency, the predominant dentoalveolar or skeletal component, and patient compliance.

The midpalatal suture — the fibrous joint between the palatal processes of the maxillary bones — undergoes progressive biological maturation from childhood to adulthood. Melsen's histological classification (1975) describes four stages: infantile (wide suture, rich in undifferentiated mesenchymal cells, mainly skeletal expansion), juvenile (intermediate stages with the onset of interdigitating complexity), adolescent (initial mineralization with an S-shaped suture pattern), and adult (progressive obliteration with bony fusion). CBCT has allowed radiographic classification of suture maturity (Angelieri's A-E staging, Am J Orthod Dentofacial Orthop, 2013) based on the MPS's appearance on axial sections: stage A (thin, high-density line) corresponds to mainly skeletal expansion, stage E (complete fusion) makes orthopedic palatal expansion impossible without surgical assistance. The correlation between CBCT stage and chronological age is imperfect: a significant percentage of 13-15 year-old patients have a suture at stage C-D, still susceptible to skeletal expansion with appropriate devices.

Available rapid palatal expansion devices are divided into tooth-supported (Hyrax, Haas, bonded RPE with occlusal coverage) and implant-supported (MARPE, Mini-screw Assisted Rapid Palatal Expansion). The Hyrax device — an open-screw RPE with bands on the first molars — is the most widely used for its simple application and extensive clinical documentation. The standard activation protocol is 0.25 mm (a quarter turn) twice a day for 2-4 weeks until overcorrecting 20-25% beyond the target (to compensate for elastic relapse during the 3-6 month consolidation phase). The bonded RPE — with acrylic coverage of the posterior teeth's occlusal surfaces — is preferred in cases with a posterior open bite component or in bruxist patients, since occlusal coverage reduces molar extrusion during expansion. The Haas device includes acrylic elements contacting the palate that, according to its designer, increase force transmission to the basal bone compared to tooth support alone; clinical differences from the Hyrax are however minimal in comparative reviews.

MARPE (Mini-screw Assisted Rapid Palatal Expansion) is the evolution for patients with a more advanced-stage suture (C-D, adolescents and young adults) where conventional tooth-supported expansion mainly produces molar tipping and limited skeletal effect. The device uses 4-6 palatal mini-screws that bypass tooth support and apply the expansion force directly to the palatal bone, distributing the load over the suture area. Results documented by Cantarella et al. (Clin Oral Implants Res, 2017) and later multicenter studies show radiographically documentable MPS opening on CBCT in 70-85% of patients with a stage C-D suture treated with MARPE, with a higher skeletal/dental ratio than conventional RPE. MARPE isn't applicable to stage E sutures (complete bony fusion): in these adult cases, SARPE (Surgically Assisted RPE) — surgical palatal osteotomy combined with an expansion device — or accepting a compensatory treatment is necessary.

Slow palatal expansion — with removable devices (expansion screw plate, Schwarz appliance) or low-force fixed devices — is indicated for transverse deficits of 2-4 mm of dentoalveolar origin (palatal tipping of premolars, functional posterior crossbite) and in patients with insufficient compliance for the RPE protocol. Expansion with a removable device requires weekly activations of 0.25-0.5 mm and 4-8 months of treatment time, with compliance of at least 16-18 hours/day. The main effect is buccal tipping of posterior teeth with modest basal expansion — enough to correct functional crossbites but insufficient for significant transverse skeletal deficits. The choice between RPE and SPE in growing patients with 3-5 mm deficits is still debated: some authors (McNamara, Baccetti) argue that RPE's skeletal effect in mixed dentition justifies systematically preferring it; others (Lee, Proffit) argue that SPE during mixed dentition followed by RPE in permanent dentition is equally effective with fewer periodontal side effects.

Adverse effects of palatal expansion — frequently underestimated in patient counseling — include: buccal gingival recession of the expanded premolars and molars (documented in 10-27% of RPE cases with 5-year follow-up, especially in patients with thin biotype), buccal alveolar bone deficit in the expanded segment detectable on CBCT (alveolar dehiscence and fenestration at variable percentages across different studies), and three-dimensional orthopedic effects on the nasomaxillary complex (nasal cavity expansion with improved airflow — generally a desired effect in mouth-breathing patients — associated with architectural changes to the nasal floor). Periodontal monitoring during and after expansion — with probing of the buccal tissue of expanded teeth and radiographic bone level checking — is recommended for early detection of recessions treatable with connective tissue grafting.